Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-002436
Filing Date
2020-01-09
Accepted
2020-01-09 08:00:10
Documents
3
Period of Report
2020-01-09

Document Format Files

Seq Description Document Type Size
1 6-K a20-1657_16k.htm 6-K 16510
2 EX-99.1 a20-1657_1ex99d1.htm EX-99.1 37828
3 GRAPHIC g16571mmi001.jpg GRAPHIC 2149
  Complete submission text file 0001104659-20-002436.txt   58593
Mailing Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 20517043
SIC: 2836 Biological Products, (No Diagnostic Substances)